CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
104.43
-0.79 (-0.75%)
At close: Jul 31, 2026, 4:00 PM EDT
104.43
0.00 (0.00%)
After-hours: Jul 31, 2026, 7:59 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Buy" and an average price target of $112.19. The average 1-year stock price forecast is 7.43% higher than the current stock price, while the lowest is $79 (-24.35%) and the highest is $148 (+41.72%).
Price Target: $112.19 (+7.43%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CVS Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 18 | 18 | 18 | 18 | 18 |
| Buy | 7 | 7 | 7 | 6 | 6 | 6 |
| Hold | 5 | 4 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 29 | 28 | 28 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $110 → $120 | Buy | Reiterates | $110 → $120 | +14.91% | Jul 29, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Buy Maintains $104 → $116 | Buy | Maintains | $104 → $116 | +11.08% | Jul 27, 2026 |
| UBS | UBS | Buy Maintains $115 → $122 | Buy | Maintains | $115 → $122 | +16.82% | Jul 24, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $108 → $118 | Buy | Maintains | $108 → $118 | +12.99% | Jul 14, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $115 → $120 | Buy | Maintains | $115 → $120 | +14.91% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
409.42B
from 399.83B
Increased by 2.40%
Revenue Next Year
426.72B
from 409.42B
Increased by 4.22%
EPS This Year
7.45
from 6.75
Increased by 10.41%
EPS Next Year
8.42
from 7.45
Increased by 12.98%
EPS and Forward PE are based on non-GAAP adjusted numbers.